Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01751412 · ClinicalTrials.gov registry record · NA

Proton Radiation for Lymphoma Involving Mediastinum

A NA study, sponsored by Massachusetts General Hospital.

Terminated
Registry status
NA
Development phase
12
Enrollment target

NCT01751412: Clinical Trial NA study, sponsored by Massachusetts General Hospital.

NCT01751412 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01751412, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.

TERMINATED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

This research study is a Pilot Study. Pilot studies are conducted to see if it is practical to do this type of research on a larger scale in the future. The pilot part of this study is to assess the possibility of using proton radiation to treat lymphomas. Proton radiation is used for many other types of malignancies, but its use for the treatment of lymphoma has been limited. The treatment is still being studied as research doctors are trying to find out more about its use in the treatment of different types of lymphoma. Proton beam radiation therapy is an FDA approved radiation delivery system. Patients are being asked to participate in this research study if they have lymphoma in the center of their chest, near their heart. Conventional radiation therapy with photons is used as standard treatment for many patients with lymphoma. In this research study investigators are looking at another type of radiation called proton radiation, which is known to spare surrounding tissue and organs from radiation. Proton radiation delivers radiation to the area requiring radiation but delivers no dose beyond the region requiring treatment. This may reduce side effects that patients would normally experience with conventional radiation therapy or other means of delivering proton radiation therapy. In this research study, investigators are evaluating the effectiveness of using proton radiation delivered to reduce side effects associated with radiation treatment.

Interventions

  • RADIATION Proton Radiation

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2013-02
Est. Completion 2017-02
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT01751412

The ClinicalTrials.gov registry entry for NCT01751412 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Proton Radiation is the first listed.

NCT01751412 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01751412 about?

NCT01751412 is a clinical study titled "Proton Radiation for Lymphoma Involving Mediastinum". This research study is a Pilot Study. Pilot studies are conducted to see if it is practical to do this type of research on a larger scale in the future. The pilot part of this study is to assess the possibility of using proton radiation to treat lymphomas. Proton radiation is used for many other typ...

What is the current status of trial NCT01751412?

This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2013-02. Estimated completion is 2017-02.

What interventions are being tested in trial NCT01751412?

The interventions under investigation include: Proton Radiation (RADIATION).

Who is sponsoring clinical trial NCT01751412?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.